Hypertension
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Office SBP from 140 to 159 mm Hg and/or DBP from 90 to 99 mm Hg for participants who did not take antihypertensive drugs previously, or Office SBP from 120 to 159 mm Hg and/or DBP from 80 to 99 mm Hg for participants who do not changing antihypertensive therapy at least 1 month; 2. Aged between 18 and 65 years (male or female); 3. Answering and completing the questionnaires; 4. Using smartphone; 5. Written informed consent.
Exclusion criteria
Exclusion criteria: 1. Other diseases that can affect the blood pressure, including but not limited to diseases of renal parenchyma, renal artery stenosis, obstructive sleep apnea syndrome, and primary hyperaldosteronism; 2. Receiving medicines that affect blood pressure except antihypertensive drugs in previous 1 month, including but not limited to glucocorticoids, central nervous system inhibitors; 3. Contraindications for the use of acupoint stimulators: wearing a pacemaker and other implanted medical devices; scars, bruises, scratches or inflammation on the skin of the acupoints; allergic to electrodes; 4. Uncontrolled diabetes (HbA1c >= 6.5%); 5. Drug or alcohol abuse; 6. Pregnant or breastfeeding; 7. Participated in other clinical trials in the past 3 months.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| the change in office systolic blood pressure; | — |
Secondary
| Measure | Time frame |
|---|---|
| the change in office diastolic blood pressure;the proportion of patients with office BP < 140/90 mmHg;the number of antihypertensive drugs and the number of participants using antihypertensive drugs;Morisky medication adherence scale (MMAS-8);Body mass index;Waist circumference;International Physical Activity Questionnaire (IPAQ);12-Item Short-Form (SF-12);Blinding assessment of valuator; | — |
Countries
China
Contacts
School of Acupuncture-Moxibustion and Tuina, Beijing University of Chinese Medicine